OVID
Ovid TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
OVID vs peer average
41/100
OVID vs. peer average (D vs. C)
Grade spread
A 2 · C 2 · D 5 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
PRTA is the first available peer comparator.
Clinical-stage neurology biotech with event-driven valuation; useful as a loose comp for how pipeline timing and readout quality can drive sentiment in CNS names.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
OVID
Ovid Therapeutics
PRTA
Prothena
Grade
D
A
Momentum
93
39
Value
41
41
Sentiment
53
87
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs PRTA
OVID / PRTA
Grade Position
Below peers
OVID vs. peer average (D vs. C)
41/100
Momentum
93
OVIDValue
41
OVIDSentiment
53
PRTARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs OVID
PRTA is the first peer returned for this comparison set.

